yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. GPCR & G Protein
  5. Cannabinoid Receptor

Cannabinoid Receptor

Cannabinoid Receptor

The three G-protein-coupled cannabinoid receptor subtypes currently recognized are central (CB1), peripheral (CB2), and GPR55. The majority of CB1 receptors are found at central and peripheral nerve terminals. CB2 receptors are mainly found in immune cells and non-neuronal tissues where they regulate cytokine release and cell migration. According to recent reports, the CNS may also express CB2 receptors. Non-CB1/CB2 receptors known as GPR55 show affinity for endogenous, botanical, and synthetic cannabinoids. Anandamide and 2-arachidonylglycerol are examples of endogenous ligands for cannabinoid receptors.

Cannabinoid Receptor related products

Structure Cat No. Product Name CAS No. Product Description
(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide V71597 (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide 220556-74-1 (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide (Compound 19) is an analog of the endocannabinoid receptor ligand Anandamide.
(R)-Monlunabant ((R)-MRI-1891) V71551 (R)-Monlunabant ((R)-MRI-1891) 2765579-76-6 (R)-Monlunabant ((R)-MRI-1891) is a CB1 receptor modulator utilized in study/research of obesity and metabolic diseases.
15(S)-HETE Ethanolamide V71573 15(S)-HETE Ethanolamide 161744-53-2 15(S)-HETE Ethanolamide is an analog of cannabinoids that works on the CB1 receptor (Ki 600 nM).
2-Linoleoyl glycerol V86543 2-Linoleoyl glycerol 3443-82-1 2-Linoleoyl glycerol (2-Monolinolein; 2-Monolinoleoylglycerol) is a monoglyceride that is an antagonist and partial agonist of the type 1 cannabinoid CB1 receptor.
2-Palmitoylglycerol (2-Palm-Gl) V71592 2-Palmitoylglycerol (2-Palm-Gl) 23470-00-0 2-Palmitoylglycerol (2-Palm-Gl) is an analog of 2-arachidonoylglycerol (2-AG) and a moderate cannabinoid receptor CB1 agonist.
2-花生酰基甘油乙腈 V5397 2-Arachidonoylglycerol 53847-30-6 2-Arachidonoylglycerol, an endocannabinoid compound, is an endogenous agonist for the cannabinoid (CB1) receptor in the central nervous system.
AChE/BChE-IN-18 V86548 AChE/BChE-IN-18 AChE/BChE-IN-18 (Compound 4g) is an AChE/BchE dual inhibitor with an IC50 value of 0.315 μM for AchE.
AEF0117 V71582 AEF0117 1610878-71-1 AEF0117 is a signaling-specific inhibitor of cannabinoid receptor 1 (CB1-SSi).
AM1241 V1516 AM1241 444912-48-5 AM-1241 (AM1241; AM 1241), anaminoalkylindole analog, is a novel, potent and selective cannabinoid (CB2) receptor agonist with potential analgesic effects (pain-killing).
AM251 V1517 AM251 183232-66-8 AM251 (AM-251; AM 251) is a novel, potent and selective cannabinoid (CB) receptor antagonist with potential anti-obesity effect.
AM841 V71584 AM841 871978-21-1 AM841 is a high-affinity electrophilic ligand.
AM8936 V71568 AM8936 2820337-96-8 AM8936 is a balanced and potent agonist of cannabinoid receptor type 1 (CB1) (EC50 for rCB1 and hCB1 of 8.6 and 1.4 nM, respectively).
Amauromine V86545 Amauromine 88360-87-6 Amauromine is a peripherally selective cannabinoid receptor type 1 (CB1) receptor antagonist with Ki and Kb values of 178 nM and 66.6 nM, respectively.
ANEB-001 V71590 ANEB-001 791848-71-0 ANEB-001 is an orally bioactive CB1 inhibitor used to study acute cannabinoid intoxication.
Arachidonoyl-N,N-dimethyl amide V86564 Arachidonoyl-N,N-dimethyl amide 45280-17-9 Arachidonoyl-N,N-dimethyl amide (Arachidonic acid-N,N-dimethyl amide) is an endocannabinoid that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
Arachidonylcyclopropylamide (ACPA) V71557 Arachidonylcyclopropylamide (ACPA) 229021-64-1 Arachidonylcyclopropylamide (ACPA) is a potent and specific CB1 receptor agonist.
AZD-1940 V7326 AZD-1940 881413-29-2 AZD1940 is an orally bioactive, high-affinity cannabinoid CB1/CB2 receptor agonist (activator) with pKis of 7.93 and 9.06 for CB1R and CB2R, respectively, and can be used for pain relief research.
Bay 59-3074 V3360 Bay 59-3074 406205-74-1 Bay 59-3074 is a novel, potent, orally active and selective cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively.
BAY-38-7271 V3361 BAY-38-7271 212188-60-8 BAY-38-7271 is novel, potent, highly selective cannabinoid receptor agonist with the potential for the treatment of traumatic brain injury.
Boc-MIF-1-Am V78516 Boc-MIF-1-Am Boc-MIF-1-Am (compound 2) is a human dopamine D2 receptor enhancer (EC50=17.82 nM) and a bioconjugate of melanostatin (MIF-1) and amantadine.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: sales@invivochem.com Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member